RECOVERY OF DOPAMINERGIC FIBERS IN STRIATUM OF THE 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-TREATED MOUSE IS ENHANCED BY GRAFTS OF ADRENAL-MEDULLA

被引：0
|
作者：
BOHN, MC [1 ]
MARCIANO, F [1 ]
CUPIT, L [1 ]
GASH, DM [1 ]
机构：
[1] SUNY STONY BROOK, DEPT NEUROBIOL & BEHAV, STONY BROOK, NY 11794 USA
来源：
PROGRESS IN BRAIN RESEARCH | 1988年 / 78卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：535 / 542
页数：8
相关论文
共 50 条
  • [21] ACUTE EFFECTS OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE ON DOPAMINE METABOLISM IN MOUSE AND RAT STRIATUM
    PILEBLAD, E
    FORNSTEDT, B
    CLARK, D
    CARLSSON, A
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1985, 37 (10) : 707 - 712
  • [22] DOPAMINERGIC NEUROTOXICITY OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) IN THE MOUSE - AN INVIVO ELECTROCHEMICAL STUDY
    GERHARDT, G
    ROSE, G
    STROMBERG, I
    CONBOY, G
    OLSON, L
    JONSSON, G
    HOFFER, B
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1985, 235 (01): : 259 - 265
  • [23] REDUCTION OF MUSCARINIC CHOLINERGIC RECEPTORS IN MOUSE STRIATUM BY 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE AND ITS RECOVERY BY LEVODOPA TREATMENT
    OGAWA, N
    SORA, YH
    SATO, H
    MIZUKAWA, K
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1987, 57 (01): : 133 - 136
  • [24] 1-METHYL-1,2,3,4-TETRAHYDROISOQUINOLINE, DECREASING IN 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-TREATED MOUSE, PREVENTS PARKINSONISM-LIKE BEHAVIOR ABNORMALITIES
    TASAKI, Y
    MAKINO, Y
    OHTA, S
    HIROBE, M
    JOURNAL OF NEUROCHEMISTRY, 1991, 57 (06) : 1940 - 1943
  • [25] Neuronal cell death in 1-methyl-4-phenyl 1,2,3,6-tetrahydropyridine-treated mice
    Fukuda, T
    Takahashi, J
    Xiang, FG
    Tanaka, J
    FRONTIERS OF THE MECHANISMS OF MEMORY AND DEMENTIA, 2000, (1200): : 79 - 82
  • [26] THE SIGNIFICANCE OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE
    MARSDEN, CD
    JENNER, PG
    CIBA FOUNDATION SYMPOSIA, 1987, 126 : 239 - 256
  • [27] Dopamine, but not norepinephrine or serotonin, reuptake inhibition reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates
    Hansard, MJ
    Smith, LA
    Jackson, MJ
    Cheetham, SC
    Jenner, P
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (03): : 952 - 958
  • [28] Neurogenesis in olfactory bulb identified by retroviral labeling in normal and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated adult mice
    Yamada, M
    Onodera, M
    Mizuno, Y
    Mochizuki, H
    NEUROSCIENCE, 2004, 124 (01) : 173 - 181
  • [29] Unilateral pallidotomy in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets exhibiting levodopa-induced dyskinesia
    Iravani, MM
    Costa, S
    Al-Bargouthy, G
    Jackson, MJ
    Zeng, BY
    Kuoppamäki, M
    Obeso, JA
    Jenner, P
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2005, 22 (06) : 1305 - 1318
  • [30] INVITRO EFFECT OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) ON MUSCARINIC CHOLINERGIC RECEPTORS IN MOUSE STRIATUM
    SUH, YH
    CHO, M
    WOO, JI
    PARK, CW
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY & ENDOCRINOLOGY, 1989, 94 (02): : 625 - 629
12345